ANALYST-DOWNGRADE filed
BNP Paribas downgraded the stock from Outperform to Neutral with a new $120 price target, down from $180, marking a double downgrade and the third downgrade in 30 days. The consensus remains moderately bullish with 68% Buy-rated (19 of 28 analysts), but momentum is deteriorating: EPS estimates have declined over the past 30 days across all periods, and institutional selling pressure is intensifying. BNP Paribas has a 33% accuracy rate (1 of 3 calls correct), well below top-tier firms like Loop Capital and HSBC (100% each). Insider selling totaled $360K in the past month, and Renaissance Technologies fully exited its position. With earnings due in 11 days and short interest at 56.7% of volume, downside risk is elevated. This downgrade aligns with weakening fundamentals and negative institutional flows.